A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study to determine the effect of ranolazine when added to metformin on glycemic control in adults with type 2 diabetes mellitus (T2DM) who are inadequately controlled despite current treatment with stable metformin therapy in addition to diet and exercise.
Epistemonikos ID: c963e254cbe5e0ceae314368437b692d98d4b7c2
First added on: May 10, 2024